1DiMeglio LA,White KE,Econs MJ.Disorders of phosphate metabolism.Endocrinol Metab Clin North Am 2000; 29:591-609.
2Shimada T,Mizutani S,Muto T,Yoneya T,Hino R,Takeda S,et al.Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.Proc Natl Acad Sci U S A 2001; 98:6500-6505.
3Xia W,Meng X,Jiang Y,Li M,Xing X,Pang L,et al.Three novel mutations of the PHEX gene in three Chinese families with X-linked dominant hypophosphatemic rickets.Calcif Tissue Int 2007; 81:415-420.
4Walton RJ,Bijvoet OL.Nomogram for derivation of renal threshold phosphate concentration.Lancet 1975; 2:309-310.
5Sommer S,Berndt T,Craig T,Kumar R.The phosphatonins and the regulation of phosphate transport and vitamin D metabolism.J Steroid Biochem Mol Biol 2007; 103:497-503.
6Shaikh A,Berndt T,Kumar R.Regulation of phosphate homeostasis by the phosphatonins and other novel mediators.Pediatr Nephrol 2008; 23:1203-1210.
7Riminucci M,Collins MT,Fedarko NS,Cherman N,Corsi A,White KE,et al.FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.J Clin Invest 2003; 112:683-692.
8Yamazaki Y,Okazaki R,Shibata M,Hasegawa Y,Satoh K,Tajima T,et al.Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.J Clin Endocrinol Metab 2002; 87:4957-4960.
9Jonsson KB,Zahradnik R,Larsson T,White KE,Sugimoto T,Imanishi Y,et al.Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.N Engl J Med 2003:348:1656-1663.
10Shimada T,Urakawa I,Yamazaki Y,Hasegawa H,Hino R,Yoneya T,et al.FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type Ila.Biochem Biophys Res Commun 2004; 314:409-414.
